For further details see:
BioVaxys initiates ovarian cancer vaccine program in Europehome / stock / lmngf / lmngf news
For further details see:
BioVaxys initiates ovarian cancer vaccine program in EuropeMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
BioVaxys Announces New Chief Financial Officer Canada NewsWire VANCOUVER, BC , Sept. 8, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") is pleased to announce that Mr. Craig Loverock ha...
BioVaxys announces completed synthesis of its Pan-Sarbecovirus Vaccine candidate and launch of in vivo animal study Canada NewsWire VANCOUVER, BC , Sept. 6, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys...
BIOVAXYS ANNOUNCES COMPLETED DEBT SETTLEMENT Canada NewsWire VANCOUVER, B.C. , Aug. 2, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") further to its news release dated July 4, 2022 , Bi...